Small Molecules

28 Sep 2017 Savara Announces Start of Pivotal Phase III AVAIL Study of AeroVanc
27 Sep 2017 Mateon Therapeutics Announces Termination of FOCUS Study in Ovarian Cancer and Restructuring to Prioritize OXi4503 for AML
27 Sep 2017 Aduro Biotech Announces Advancement of ADU-S100 into Global Combination Trial With PDR001 for the Treatment of Solid Tumors and Lymphomas
27 Sep 2017 Lexicon Pharmaceuticals Initiates Patient Dosing In A Phase 1 Study Of LX9211
27 Sep 2017 Intellia Therapeutics Demonstrates Sustained and Durable Genome Editing with CRISPR/Cas9 in One-Year Animal Study
27 Sep 2017 Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer's Disease
26 Sep 2017 European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe
26 Sep 2017 Medivir Announces Positive Topline Results from Phase IIa Osteoarthritis Study, Showing Disease-modifying Benefit of MIV-711 on Joint Structure
26 Sep 2017 Gelesis100 Achieves Significant Weight Loss with Excellent Safety Profile in Pivotal Study
25 Sep 2017 Janssen Submits New Drug Application to U.S. Food and Drug Administration for the First Darunavir-Based Single Tablet Regimen for the Treatment of HIV-1
25 Sep 2017 Shionogi Announces Results for Lusutrombopag (S-888711) Phase 3 Study (L-PLUS2) for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
25 Sep 2017 NewLink Genetics Announces Clinical Collaboration to Evaluate IO-Based Combination Therapies in Pancreatic Cancer
25 Sep 2017 Athenex, Inc. Announces First Patient Recruitment in Phase III Clinical Trials for KX-01 Ointment for Actinic Keratosis
25 Sep 2017 Acer Therapeutics Reports Positive Results From Pivotal Clinical Trial of EDSIVO™ (celiprolol) for Treatment of Vascular Ehlers-Danlos Syndrome
25 Sep 2017 Prometic receives FDA clearance of its IND to initiate pivotal PBI-4050 Phase 2/3 trial in patients with idiopathic pulmonary fibrosis
25 Sep 2017 AMO Pharma Reports Update on Positive Interim Analysis for the First Cohort of Phase IIa Congenital Myotonic Dystrophy Study
25 Sep 2017 Combination of Optune® with Temozolomide Demonstrates Unprecedented Five-Year Survival for Newly Diagnosed Glioblastoma Patients
25 Sep 2017 Daiichi Sankyo Initiates Pivotal Phase 3 study in Japan of Esaxerenone in Patients with Diabetic Nephropathy
25 Sep 2017 Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Study in Japan of Esaxerenone for Treatment of Essential Hypertension
24 Sep 2017 Allergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) Supplemental New Drug Application (sNDA) for the Treatment of Negative Symptoms in Schizophrenia
22 Sep 2017 Dova Pharmaceuticals Announces New Drug Application Submission to FDA for Avatrombopag, a Second Generation Thrombopoietin Receptor Agonist
22 Sep 2017 Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus
22 Sep 2017 New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial
21 Sep 2017 FLX Bio Selects Immuno-Oncology Clinical Candidate
21 Sep 2017 BioCryst's RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing